Table 4 Risks associated with allogeneic red cell transfusion rate
Allogeneic red cell transfusion (n = 15) | None (n = 45) | P value | |
|---|---|---|---|
Age (years) | 49.7 ± 15.7 | 48.6 ± 14.6 | 0.799 |
Male, % | 10 (66.7%) | 28 (62.2%) | 0.757 |
Body mass index | 24.1 ± 3.2 | 23.0 ± 3.2 | 0.270 |
Recurrence glioblastoma, % | 3 (20%) | 5 (11.1%) | 0.661 |
Deep location, % | 8 (53.3%) | 17 (37.8%) | 0.290 |
Tumor size (mm) | 5.9 ± 1.9 | 4.6 ± 2.1 | 0.034 |
Preoperative hemoglobin (g/dL) | 13.3 ± 2.4 | 13.3 ± 1.7 | 0.959 |
Estimated blood loss (mL) | 910.0 ± 333.9 | 300.0 ± 152.6 | < 0.001 |
Length of surgery (min) | 306.6 ± 82.7 | 220.8 ± 64.5 | < 0.001 |